Edap Tms SA
NASDAQ:EDAP

Watchlist Manager
Edap Tms SA Logo
Edap Tms SA
NASDAQ:EDAP
Watchlist
Price: 2.2025 USD 3.4% Market Closed
Market Cap: 81.7m USD
Have any thoughts about
Edap Tms SA?
Write Note

Edap Tms SA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Edap Tms SA
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Edap Tms SA
NASDAQ:EDAP
Operating Income
-€19.8m
CAGR 3-Years
N/A
CAGR 5-Years
-72%
CAGR 10-Years
-22%
Biomerieux SA
PAR:BIM
Operating Income
€519.5m
CAGR 3-Years
-9%
CAGR 5-Years
8%
CAGR 10-Years
9%
Carmat SA
PAR:ALCAR
Operating Income
-€52m
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
-9%
Visiomed Group SA
PAR:ALVMG
Operating Income
€230k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theradiag SA
PAR:ALTER
Operating Income
€690k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amplitude Surgical SA
PAR:AMPLI
Operating Income
€10m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Edap Tms SA
Glance View

Market Cap
81.3m USD
Industry
Health Care

EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.

EDAP Intrinsic Value
4.2 USD
Undervaluation 48%
Intrinsic Value
Price

See Also

What is Edap Tms SA's Operating Income?
Operating Income
-19.8m EUR

Based on the financial report for Dec 31, 2023, Edap Tms SA's Operating Income amounts to -19.8m EUR.

What is Edap Tms SA's Operating Income growth rate?
Operating Income CAGR 10Y
-22%

Over the last year, the Operating Income growth was -365%.

Back to Top